Tag: Perjeta

Roche breast cancer drug combo cuts death rate and recurrence

Roche breast cancer drug, Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and chemotherapy has been demonstrated in a phase 3 trial to have cut the ... Read More